Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03771105 · ClinicalTrials.gov registry record · Early Phase 1
The Impact of Phosphate Metabolism on Healthy Aging
A Early Phase 1 study, sponsored by Yale University.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
NCT03771105 is a Early Phase 1 study that is actively recruiting participants, run by Yale University. The registered enrollment target is 30 participants.
The verdict
NCT03771105, a Early Phase 1 study, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
Determine the association between duration and dose of chronic conventional therapy with Pi and renal (nephrocalcinosis/nephrolithiasis), vascular (endothelial function), and cardiovascular function (echo- cardiography) in patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH) and patients with X-linked hypophosphatemia (XLH).
Interventions
- DRUG phosphate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2028-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03771105
The ClinicalTrials.gov registry entry for NCT03771105 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which phosphate is the first listed.
NCT03771105 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03771105 about?
NCT03771105 is a clinical study titled "The Impact of Phosphate Metabolism on Healthy Aging". Determine the association between duration and dose of chronic conventional therapy with Pi and renal (nephrocalcinosis/nephrolithiasis), vascular (endothelial function), and cardiovascular function (echo- cardiography) in patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH) ...
What is the current status of trial NCT03771105?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2019-01-01. Estimated completion is 2028-04.
What interventions are being tested in trial NCT03771105?
The interventions under investigation include: phosphate (DRUG).
Who is sponsoring clinical trial NCT03771105?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.